Update on the systemic treatment of malignant melanoma

被引：14

作者：

Lawson, DH ^{[1
]}

机构：

[1] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA

来源：

SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 02期

关键词：

D O I：

10.1053/j.seminoncol.2004.02.014

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：33 / 37

页数：5

共 43 条

[31] Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma [J].

Phan, GQ ;

Yang, JC ;

Sherry, RM ;

Hwu, P ;

Topalian, SL ;

Schwartzentruber, DJ ;

Restifo, NP ;

Haworth, LR ;

Seipp, CA ;

Freezer, LJ ;

Morton, KE ;

Mavroukakis, SA ;

Duray, PH ;

Steinberg, SM ;

Allison, JP ;

Davis, TA ;

Rosenberg, SA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8372-8377

[32] Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma [J].

Phan, GQ ;

Attia, P ;

Steinberg, SM ;

White, DE ;

Rosenberg, SA .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (15) :3477-3482

[33]

Reintgen D, 2000, IN VIVO, V14, P213

[34] Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2 - Identification of the antigens mediating response [J].

Rosenberg, SA ;

Yang, JC ;

White, DE ;

Steinberg, SM .

ANNALS OF SURGERY, 1998, 228 (03) :307-317

[35] Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma [J].

Rosenberg, SA ;

Yang, JC ;

Schwartzentruber, DJ ;

Hwu, P ;

Marincola, FM ;

Topalian, SL ;

Restifo, NP ;

Dudley, ME ;

Schwarz, SL ;

Spiess, PJ ;

Wunderlich, JR ;

Parkhurst, MR ;

Kawakami, Y ;

Seipp, CA ;

Einhorn, JH ;

White, DE .

NATURE MEDICINE, 1998, 4 (03) :321-327

[36]

Sandor V, 2002, CLIN CANCER RES, V8, P718

[37] Guidelines for the safe administration of high-dose interleukin-2 [J].

Schwartzentruber, DJ .

JOURNAL OF IMMUNOTHERAPY, 2001, 24 (04) :287-293

[38]

SHARMA R, 2003, P AN M AM SOC CLIN, V22, P712

[39] Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor [J].

Spitler, LE ;

Grossbard, ML ;

Ernstoff, MS ;

Silver, G ;

Jacobs, M ;

Hayes, FA ;

Soong, SJ .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) :1614-1621

[40]

WEBER JS, 2003, P AN M AM SOC CLIN, V22, P710

← 1 2 3 4 5 →